Mst Continus (Morphine Sulfate)

Morphine sulfate acts as a full agonist at mu‑opioid receptors in the central nervous system. By activating these receptors, it inhibits the transmission of nociceptive signals and alters pain perception, producing analgesia and sedation.

The dose is individualized by the prescribing clinician based on pain severity, the patient’s opioid tolerance, renal and hepatic function, and other clinical considerations. No fixed regimen is provided here.

Safety in pregnancy and lactation has not been established. Morphine can cross the placenta and enter breast milk, so use is generally avoided unless the potential benefit justifies the potential risk and it is discussed with a healthcare professional.

Submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Morphine sulfate is considered a benchmark opioid. Compared with alternatives such as oxycodone or fentanyl, it has a well‑characterized efficacy and side‑effect profile, but differences in potency, duration of action and formulation may influence selection based on specific clinical needs.

Store at room temperature, below 25 °C, in the original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and unauthorized persons.

The product is intended for oral administration. Tablets or capsules are swallowed whole with water, and dosing intervals are determined by the prescriber to maintain adequate pain control while minimizing adverse effects.

The most critical risks include respiratory depression, severe hypotension, profound sedation, dependence or addiction, and the potential for life‑threatening allergic reactions. Patients should be monitored closely, especially during initiation and dose adjustments.

Individuals with known hypersensitivity to morphine or other opioids, those with significant respiratory insufficiency, acute or severe asthma, paralytic ileus, or uncontrolled severe head injury should avoid using this medication, as it is contraindicated in such conditions.